INTERNATIONAL CONFERENCE
ON THE NCD EPIDEMIC
02 Days – 01 Theme
86 Speakers
14 Sessions – 03 Panels
Republic of Senegal
African Union
World Health Organization
NCDs Alliance
Low funding for medical research in Africa
Research topics are chosen by funding countries rather than by African countries themselves;
90% of the funds allocated to medical research on the continent are still devoted to infectious diseases, even though non-communicable diseases are the leading cause of death in Africa.
It’s time !
African doctors should be able to choose the diseases they wish to work on, create and carry out the studies and tests of their choice, analyse, publish and benefit from the results themselves.
The Dakar Call
on the theme:
THE EPIDEMIC OF NON-COMMUNICABLE DISEASES IN AFRICA
DECLARATION OF DAKAR ESTABLISHMENT OF THE AFRICAN RESEARCH INSTITUTE (ARI)
– Research on NCDs: assessment of the situation in Africa.
– The response of the African Research Network.
- New approaches to financing
- The response of the African research network
- A growing community
- Objective of ARN
This scientific meeting will bring together the academic and global health communities, funding bodies (development agencies, private sector), ministries of higher education, research and innovation, ministries of health, deans and scientists from the countries in the ARN network.
To enable the production of high-quality global health research in Africa and train the next generation of international research leaders, in 2018 we established the African Research Network.
The ARN is a growing community of cardiologists, epidemiologists and pharmacists from 37 medical centres and 14 universities in 20 sub-Saharan African countries, and there’s more to come!
Our aim is to produce meaningful data to minimise the unknowns around the prevalence and aetiology of non-communicable diseases in Africa. RNA’s work is regularly published in leading global health journals and includes studies on rheumatic heart disease, sickle cell disease, epidemiological transition, the quality of cardiovascular and anti-diabetic drugs, severe hypertension and acute rheumatic arthritis.
Speakers
Assoumani
Sall
Ghebreyesus
Mukwege
Our sponsors
Partners
Universities
